Samsung Biologics, BMS Ink 10-Year Cancer Antibody Partnership
This article was originally published in PharmAsia News
Executive Summary
Samsung Biologics and Bristol-Myers Squibb formed a 10-year partnership to produce the U.S.-based company's antibody cancer drug in South Korea.